Peginesatide
Erythropoiesis-stimulating Agent — BLOOD AND BLOOD FORMING ORGANS
Also known as: AF-37702, hematide, omontys, peginesatide acetate
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Peginesatide is a drug in the Erythropoiesis-stimulating Agent class catalogued in DrugCentral. It was first approved by the FDA in 2012. DrugCentral lists 1 molecular target, including EPOR. Recorded indications include Anemia in chronic kidney disease.
- Drug class: Erythropoiesis-stimulating Agent.
- Molecular targets: EPOR (1 listed in DrugCentral).
- Indications: Anemia in chronic kidney disease.
- ATC code: B03XA04 (Other antianemic preparations).
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Anemia in chronic kidney disease
Mechanism & targets
| Established pharmacologic class | Erythropoiesis-stimulating Agent |
|---|
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Erythropoietin receptor | EPOR | agonist | IC50 10.43 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2012-03-27 | FDA | — | TAKEDA PHARMS USA |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
B03XA04 | BLOOD AND BLOOD FORMING ORGANS › ANTIANEMIC PREPARATIONS › OTHER ANTIANEMIC PREPARATIONS › Other antianemic preparations |
Chemical structure
| Molecular formula | — |
|---|---|
| Molecular weight | — |
| CAS number | — |
| InChIKey | — |
| PubChem CID | — |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Peginesatide used for?
DrugCentral lists the following indications for Peginesatide: Anemia in chronic kidney disease.
How does Peginesatide work?
Its molecular targets in DrugCentral include EPOR (agonist).
When was Peginesatide first approved?
Peginesatide was first approved by the FDA in 2012.
What drug class does Peginesatide belong to?
Peginesatide is in the Erythropoiesis-stimulating Agent class.
Browse: all drugs starting with P · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4234 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1963684 — compound record and bioactivity
- DrugBank DB08894 — drug record
- FDA UNII JX56W9N61Q — substance identity
- DailyMed: FDA labels for Peginesatide — current prescribing information (label search)
- UniProt P19235 (EPOR) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.